Depression - Articles - Page 11

Methylphenidate Improves Mood and Boredom in Children with ADHD

March 24, 2022

Pavan Madan, MD. Dr. Madan has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Kids with ADHD often complain that they are bored. But what does that really mean? And many are also depressed. Does treating the ADHD help these symptoms? We looked a study that tries to break this down and give us a way forward, while offering some new insights on the relationships between ADHD, mood and boredom - important and useful symptoms to track.

Electroconvulsive Therapy: A Primer

March 23, 2022

Stephen J. Seiner, MD

Stephen J. Seiner, MD Director of neurotherapeutics, McLean Hospital. Belmont, MA. Dr. Seiner has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Dr. Seiner runs one of the busiest ECT programs in the country and speaks to us about recent innovations in the procedure. He also tells us which patients are the best candidates and shares tips for how to prolong ECT’s benefits.

EXPERT Q&A

Mental Illness and Flourishing

March 4, 2022

Margaret Chisolm, MD

Margaret Chisolm, MD Vice Chair for Education in Psychiatry and Behavioral Sciences at Johns Hopkins University. Author of From Survive to Thrive: Living Your Best Life With Mental Illness (2021). Dr. Chisolm has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Photo credit: Greg Dohler

Dr. Margaret Chisolm shares how she and many of her colleagues at Johns Hopkins have found success in working with patients through a unique yet workable lens.

Oral Zuranolone for Postpartum Depression

March 4, 2022

Michael Posternak, MD.

Michael Posternak, MD. Dr. Posternak has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

If approved, this alternative to IV brexanolone will be a more practical option for treating PPD.

Intravenous Ketamine for Teen Depression

January 31, 2022

Pavan Madan, MD.

Pavan Madan, MD. Dr. Madan has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Ketamine is a hot topic in the treatment of adults with severe depression. But how effective is ketamine in adolescents? This research update looks at some emerging data to help you decide whether off label use of ketamine might be a viable option in teens with severe depression.

The Role of rTMS in Poststroke Depression

January 7, 2022

Susan L. Siegfreid, MD

Susan L. Siegfreid, MD Dr. Siegfreid has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Repetitive transcranial magnetic stimulation appears to be a safe and effective treatment for poststroke depression, according to this small study.

Light Therapy: Good for What Ails You?

September 28, 2021

Edmund S. Higgins, MD.

Edmund S. Higgins, MD. Clinical associate professor, Psychiatry and Behavioral Sciences, Medical University of South Carolina. Dr. Higgins has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The health benefits of light therapy are expanding its use beyond winter depression. Here we explore those promises and pitfalls, including ADHD, PTSD, bipolar depression, binge eating, sleep disorders, dementia, sexual dysfunction, traumatic brain injury, diabetes, and arthritis.

Can We Treat Depression by Targeting Inflammation?

September 13, 2021

Christina Guest, MD.

Christina Guest, MD. Dr. Guest has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

If inflammation plays a role in mood, it makes sense to explore the effects of antibiotics on depression. This study does just that.

Psilocybin vs Escitalopram for Depression

September 10, 2021

Michael Posternak, MD.

Michael Posternak, MD. Dr. Posternak has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Psilocybin is inching its way toward FDA approval in depression, but will this trial from the New England Journal of Medicine help it along or set it back?

ECT Worked: Now What?

August 3, 2021

Michael Posternak, MD.

Michael Posternak, MD. Psychiatrist in private practice, Boston, MA. Dr. Posternak has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Your patient has recovered from depression with ECT, but their chances of going back into it are high (80%). In this article, learn 3 ways to reduce that risk.